MONDAY, AUGUST 21, 2017

Wake Forest researchers use online game to study flu outbreaks

Frederick Chen Read More »

HPA identifies case of novel coronavirus in United Kingdom

Coronavirus Read More »

U.K. measles outbreak caused in part by Wakefield study

Measles Read More »

CDC reports increasing use of immunization information systems

The U.S. Centers for Disease Control and Prevention recently reported that child participation in immunization systems increased from 2006 to 2011. Read More »

UNDP administrator calls for permanent spotlight on noncommunicable diseases

Helen Clark Read More »

Study: One-third of hepatitis B and C cases in Pakistan are preventable

Hepatitis B Read More »

Oral cancer treatment shows success in Phase I/II trials

VAXIMM AG, a Swiss-German biotech company specializing in oral cancer vaccines, recently announced that Phase I/II dose escalation clinical trials for its cancer vaccine, VXM01, demonstrated the drug's safety and tolerability. Read More »

Kimberly-Clark increasing facemask production in response to influenza

The Kimberly-Clark Corporation recently announced that it would continue to increase production of facemasks and personal protective equipment in response to ongoing near epidemic levels of influenza in the United States. Read More »

TB infection could return to former prevalence

Tuberculosis Read More »

WHO makes no change to risk assessment for novel coronavirus

Coronavirus Read More »

Intercell vaccine granted approval for children in Europe

Intercell AG recently announced that the pediatric indication for its vaccine against Japanese Encephalitis, IXIARO, was granted marketing authority by European regulators. Read More »

New Zealand, Australia to collaborate on rheumatic fever research

Peter David Gluckman Read More »

IOM releases cancer care workshop summary

The Institute of Medicine, a non-profit organization that provides unbiased, authoritative advice to government decision makers and the public, released its summary of a cancer care workshop on Monday. Read More »

India introduces stricter compensation laws for clinical trial injuries

The government of India recently introduced stricter compensation laws and regulations for clinical trials to counter the previous lack of reasonable care and financial compensation connected to the trials. Read More »

Bavarian Nordic to discuss prostate cancer vaccines at upcoming symposium

Bavarian Nordic recently announced that its researchers will present four abstracts on two vaccines for treating prostate cancer at an upcoming conference. Read More »

U.S., EU discuss vaccine development

Robert-Jan Smits Read More »

Pharmacyclics announces BTD for investigational oncology drug

Pharmacyclics, a clinical-stage biopharmaceutical company, announced on Tuesday that the U.S. Food and Drug and Administration had granted a breakthrough therapy designation for an investigational drug to treat patients with relapsed or refractory mantle cell lymphoma. Read More »

Lycera, Merck team up again to fight autoimmune diseases

Lycera Corp., an Ann Arbor, Michigan-based biopharmaceutical company, recently announced a partnership with the New Jersey-based pharmaceutical company Merck & Co., Inc., to develop small molecules against undisclosed targets for autoimmune diseases. Read More »

Xencor begins clinical trial of arthritis drug

Pharmaceutical company Xencor, Inc., recently announced that it has started a Phase Ib/IIa clinical trial for a rheumatoid arthritis treatment. Read More »

TNFi arthritis patients show changes in brain activity before improvement

Changes in brain activity before signs of improvement have been seen in patients with rheumatoid arthritis who respond to necrosis factor inhibitors. Read More »